Johnson & Johnson
NYSE:JNJ
$ 232,77
+ $4,60 (2,02%)
232,77 $
+$4,60 (2,02%)
End-of-day quote: 06/05/2026

News

Wells Fargo Maintains Overweight on Johnson & Johnson, Raises Price Target to $263

Wells Fargo analyst Larry Biegelsen maintains Johnson & Johnson (NYSE:JNJ) with a Overweight and raises the price target from $240 to $263.

04/15/2026

Transcript: Johnson & Johnson Q1 2026 Earnings Conference Call

04/15/2026

Johnson & Johnson Q1 2026 Earnings Call Transcript

Johnson & Johnson (NASDAQ: JNJ) reported first-quarter financial results on Tuesday. The transcript from the company's first-quarter earnings call has been provided below.

04/14/2026

Johnson & Johnson Q1 Performance: Cancer Drug Revenue Grows, Free Cash Flow Falls, Hikes Dividend

Johnson & Johnson Q1 pharma growth offsets immunology decline; company raises guidance and extends dividend streak.

04/14/2026

Earnings Scheduled For April 14, 2026

04/14/2026

Johnson & Johnson Raises FY2026 Adj EPS Guidance from $11.43-$11.63 to $11.45-$11.65 vs $11.54 Est; Raises FY2026 Sales Guidance from $100.000B-$101.000B to $100.300B-$101.300B vs $100.575B E

Johnson & Johnson (NYSE:JNJ) raises FY2026 Adj EPS guidance from $11.43-$11.63 to $11.45-$11.65 vs $11.54 analyst estimate. Raises FY2026 sales outlook from $100.000 billion-$101.000 billion to $100.300 billion-$101.300

04/14/2026

Johnson & Johnson Board Approves 3.1% Quarterly Dividend Hike To $1.34 Per Share, Payable June 9

At the new rate, the indicated dividend on an annual basis is $5.36 per share compared to the previous rate of $5.20 per share. The next quarterly dividend is payable on June 9, 2026 to shareholders of record at the

04/14/2026

Johnson & Johnson Q1 Adj. EPS $2.70 Beats $2.67 Estimate, Sales $24.062B Beat $23.630B Estimate.

Johnson & Johnson (NYSE:JNJ) reported quarterly earnings of $2.70 per share which beat the analyst consensus estimate of $2.67 by 1.12 percent. This is a 2.53 percent decrease over earnings of $2.77 per share from the

04/14/2026

Dow Jones Stocks In Spotlight: JPMorgan, Johnson & Johnson Among This Week's Earnings Reports

Four of the 30 Dow Jones Industrial Average stocks report this week. Here's a look at the companies and what the key figures to watch are.

04/13/2026

ASML, JPMorgan And More Stocks With Earnings This Week

The Q1 earnings season gets underway this week with reports from major banks, including Goldman Sachs and JPMorgan and tech company ASML.

04/13/2026
×
Logo
Offer & Services
Features
Pricing
Masters
Trend
Radar
Service & Collaboration
Contact
Help
Affiliate Program
Stock Market Glossary
Company & Legal
Impressum
Privacy Policy
Terms and Conditions

© Copyright 2026 | GROWTH Investing | All Rights Reserved

Important note:

Please note that we do not offer financial services such as investment advice, asset management, or financial brokerage. Our website is solely for providing information and educational content on modern financial strategies and stock analysis. All information presented on this website is for educational purposes and should not be construed as specific investment recommendations. We do not manage client funds and assume no responsibility for individual investment decisions. Each participant is responsible for their own financial decisions and should consult an independent financial advisor if necessary.

The successes, participation figures, and information presented here, provided by Growth Services LLC, are based on our own experiences and those of our clients in the field of stock and chart analysis. They should not be interpreted as an absolute guarantee or a firm promise. Individual success results can vary significantly and depend on numerous factors. The successes presented in our case studies and testimonials reflect the actual results of ourselves and our most dedicated participants and are intended as inspiration, not as a binding commitment. Our offering aims to equip you with the necessary knowledge and skills to perform optimally in the stock market. While we are committed to the success of each individual, we cannot guarantee specific results. Proactive participation and dedication from our clients are essential for success.

This site is not a part of the Facebook, Instagram website or Meta Platforms Inc. Additionally, This site is NOT endorsed by Meta Platforms in any way. FACEBOOK is a trademark of Meta Platforms, Inc.

This website is not affiliated with, endorsed by, or operated by Google LLC. Google is a registered trademark of Google LLC. Our service and offerings are not directly connected to the products or services of Google.